Document Detail

The dilemma of mild hyperprolactinaemia.
MedLine Citation:
PMID:  6594127     Owner:  NLM     Status:  MEDLINE    
Ninety-eight women with mild hyperprolactinaemia (less than 4N) were followed for a mean duration of 5.5 years. Where pregnancy was desired treatment with bromocriptine (+/- clomiphene) was effective in 87%. Following cessation of bromocriptine therapy almost one-third had a 'spontaneous' resolution of hyperprolactinaemia and resumed cyclical menstrual activity and fertility. Pituitary tumours were identified on coned-view assessment in 9% of patients at the time of presentation and a further 10% during follow-up. Although some of these latter tumours may have been diagnosed earlier had CAT scans been performed routinely in all hyperprolactinaemic patients, such a policy would be hard to justify for those with mild hyperprolactinaemia as the tumours were small, produced no harmful effects, and would almost certainly have responded to bromocriptine should this have been administered. All patients found to have pituitary tumours and given bromocriptine, showed no evidence of tumour progression subsequently, even where pregnancy occurred and the bromocriptine therapy was ceased. In addition, patients without pituitary tumours who were given bromocriptine to achieve pregnancy, were less likely to develop tumours during follow-up even when pregnancy had occurred. Bromocriptine therapy can thus be justified in mildly hyperprolactinaemic patients to reduce troublesome galactorrhoea, achieve pregnancy, improve the chance of 'spontaneous' resolution of the menstrual problem and infertility, control or reduce tumour growth where a pituitary tumour has been identified, and reduce the risk of tumour development in patients with normal radiographs at the time of presentation.
R J Pepperell; C Martinez; A Dickinson
Related Documents :
7277167 - Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of th...
17875487 - Age-specific changes in sex steroid biosynthesis and sex development.
11999317 - Fetal control of parturition in marsupials.
18450957 - Inhibition of brain prostaglandin endoperoxide synthase-2 prevents the preparturient in...
21964517 - Contribution of cryopreservation in a mandatory set policy: analysis of 5 years of appl...
15911177 - Relationships between sexual behaviour, dominant follicle area, uterus ultrasonic image...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Australian & New Zealand journal of obstetrics & gynaecology     Volume:  24     ISSN:  0004-8666     ISO Abbreviation:  Aust N Z J Obstet Gynaecol     Publication Date:  1984 May 
Date Detail:
Created Date:  1984-12-07     Completed Date:  1984-12-07     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0001027     Medline TA:  Aust N Z J Obstet Gynaecol     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  117-20     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bromocriptine / therapeutic use
Follow-Up Studies
Pituitary Neoplasms / complications,  epidemiology,  radiography
Prolactin / blood*
Reg. No./Substance:
25614-03-3/Bromocriptine; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Parents who physically abuse their children.
Next Document:  Unexplained infertility and the possibilities of management with in vitro fertilization and embryo t...